MEMORIAL SLOAN-KETTERING CANCER CENTER

EIN: 912154267 501(c)(3) Health Care

NEW YORK, NY

Total Revenue
$7,462,624,000
Total Expenses
$7,188,709,398
Total Assets
$14,659,485,000
Net Assets
$9,237,367,000
🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Sign In — Free (10 views/day)

Financial Trends

Organization Details

Phone
6462273092
Tax Period
2023-01-01 to 2023-12-31

MEMORIAL SLOAN-KETTERING CANCER CENTER is a large national nonprofit in the Health Care sector that reported $7.5B in total revenue in fiscal year 2023. Expenses of $7.2B left a modest 4% surplus.

Mission

THE MISSION OF MEMORIAL SLOAN-KETTERING CANCER CENTER IS TO LEAD IN THE PREVENTION, DIAGNOSIS, TREATMENT AND CURE OF CANCER AND ASSOCIATED DISEASES THROUGH PROGRAMS OF EXCELLENCE IN RESEARCH, EDUCATION, OUTREACH AND COST-EFFECTIVE PATIENT CARE. LEADERSHIP IN PATIENT CARE: WE PLACE THE HIGHEST PRIORITY ON ADVANCING THE CARE OF CANCER PATIENTS THROUGH EARLY DETECTION, ACCURATE DIAGNOSIS, AND OPTIMAL TREATMENT. THESE THREE ELEMENTS LEAD TO THE MOST EFFECTIVE CANCER CARE POSSIBLE, WHICH IS ALSO THE MOST COST-EFFECTIVE CARE. WE STRIVE FOR EXCELLENCE IN ALL EXISTING AND EMERGING THERAPIES WITHOUT NEGLECTING THE NEED FOR ADVANCED APPROACHES IN PALLIATION. WE DELIVER THESE THERAPIES IN A CARING ENVIRONMENT THAT ENCOMPASSES PATIENTS AS WELL AS THEIR LOVED ONES. EXCELLENCE IN PATIENT CARE IS EXEMPLIFIED BY OUR MULTIDISCIPLINARY APPROACH, A CORE COMPETENCE OF OUR CENTER. WE ARE COMMITTED TO DEVELOPING OUTREACH PROGRAMS TO BRING EXCELLENCE IN CANCER CARE TO THE COMMUNITY. LEADERSHIP IN RESEARCH EXCELLENCE: PATIENT CARE REQUIRES THE EXPEDITIOUS APPLICATION OF NEW KNOWLEDGE DISCOVERED THROUGH RIGOROUS LABORATORY AND CLINICAL RESEARCH. THE INTERRELATIONSHIP BETWEEN SCIENTIFIC DISCOVERY AND ITS APPLICATION TO PATIENT CARE DEFINES OUR UNIQUE NATURE AT ITS BEST. LEADERSHIP IN EDUCATION: TO ENSURE PROGRESS, WE ARE DEDICATED TO PROVIDING THE FINEST EDUCATION AND TRAINING FOR THE MOST PROMISING YOUNG SCIENTISTS, CLINICIANS, AND OTHER HEALTHCARE PROFESSIONALS. PUBLIC AND PATIENT EDUCATION ARE ALSO CORNERSTONES FOR PROGRESS AND SUCCESS IN PATIENT CARE, ESPECIALLY IN PREVENTION, EARLY DETECTION, AND COMPLIANCE DURING THERAPY AND MAINTENANCE PROGRAMS. RESOURCES FOR LEADERSHIP: WE ARE STAFFED WITH THE HIGHEST-QUALITY PROFESSIONALS WHO HAVE A FULL-TIME COMMITMENT TO OUR MISSION. WE ARE DETERMINED TO PROVIDE OUR STAFF AND OUR PATIENTS WITH THE FINEST STATE-OF-THE-ART FACILITIES, TECHNOLOGY, MANAGEMENT, AND SUPPORT SERVICES. RESPONSIBILITIES OF LEADERSHIP: MEMORIAL SLOAN-KETTERING CANCER CENTER IS A LEADER IN CANCER RESEARCH AND TREATMENT, OFFERING PATIENTS THE MOST SOPHISTICATED, COMPASSIONATE, AND STATE-OF-THE-ART CARE AVAILABLE AND ADVANCING THE KNOWLEDGE THAT WILL IMPROVE THAT CARE IN THE FUTURE. THE CLOSE COLLABORATION BETWEEN OUR PHYSICIANS AND SCIENTISTS IS ONE OF OUR UNIQUE STRENGTHS, ENABLING US TO PROVIDE PATIENTS WITH THE BEST CARE POSSIBLE AS WE WORK TO DISCOVER MORE-EFFECTIVE STRATEGIES TO PREVENT, CONTROL, AND ULTIMATELY CURE CANCER.

Program Service Accomplishments

Program 1
Expenses: $5,863,755,670 Revenue: $6,105,881,000

INCLUDED IN FORM 990 IS SEVERANCE PAY: KATHRYN MARTIN $1,117,022 ROXANNE TAYLOR $778,125 FREDRICK GROVES $308,655 AMADOR CENTENO $153,365 MARGARET BURKE $132,180

Program 2
Expenses: $975,731,057 Revenue: $201,058,000

RESEARCH: MEMORIAL SLOAN-KETTERING CANCER CENTER MAINTAINS ONE OF THE WORLD'S MOST DYNAMIC PROGRAMS OF CANCER RESEARCH. THE EXTRAORDINARY PATIENT CARE WE PROVIDE BENEFITS FROM OUR INNOVATIVE PROGRAMS...

Read more

RESEARCH: MEMORIAL SLOAN-KETTERING CANCER CENTER MAINTAINS ONE OF THE WORLD'S MOST DYNAMIC PROGRAMS OF CANCER RESEARCH. THE EXTRAORDINARY PATIENT CARE WE PROVIDE BENEFITS FROM OUR INNOVATIVE PROGRAMS IN BASIC, TRANSLATIONAL, AND CLINICAL RESEARCH. RESEARCH AT SLOAN-KETTERING INSTITUTE IS DEDICATED TO UNDERSTANDING THE BIOLOGY OF CANCER THROUGH PROGRAMS IN CELL BIOLOGY, ENETICS, BIOCHEMISTRY, MOLECULAR BIOLOGY, STRUCTURAL BIOLOGY, COMPUTATIONAL BIOLOGY, IMMUNOLOGY, AND THERAPEUTICS. INVESTIGATORS AT SLOAN-KETTERING INSTITUTE COLLABORATE WITH MEMORIAL HOSPITAL PHYSICIAN-SCIENTISTS, A PARTNERSHIP THAT HELPS SPEED IMPORTANT RESEARCH FINDINGS FROM THE LABORATORY TO THE BEDSIDE, IN A PROCESS KNOWN AS TRANSLATIONAL RESEARCH. MEMORIAL SLOAN-KETTERING CANCER CENTER ALSO ACTIVELY INITIATES AND PARTICIPATES IN CLINICAL TRIALS TO IDENTIFY MORE EFFECTIVE CANCER THERAPIES, AND OUR PHYSICIANS ARE CURRENTLY LEADING MORE THAN 1,900 CLINICAL TRIALS FOR PEDIATRIC AND ADULT CANCERS. THE HUMAN ONCOLOGY AND PATHOGENESIS PROGRAM (HOPP) IS A FURTHER EFFORT TO INCREASE INSTITUTIONAL RESEARCH STRENGTH IN AREAS IMPORTANT IN CONTEMPORARY TRANSLATIONAL RESEARCH. HOPP IS DESIGNED TO MELD EVEN MORE THOROUGHLY THE CULTURES OF BASIC BIOLOGIC SCIENCE AND CLINICAL ONCOLOGY, AUGMENTING THE WORK CONDUCTED IN THE LABORATORIES OF MEMORIAL SLOAN-KETTERING CANCER CENTER'S PHYSICIAN-SCIENTISTS.

Program 3
Expenses: $240,313,367 Revenue: $0

EDUCATION: EDUCATION IS A VITAL PART OF MEMORIAL SLOAN-KETTERING CANCER CENTER'S MISSION. OUR TRAINING PROGRAMS PREPARE PHYSICIANS AND SCIENTISTS FOR CAREERS IN THE BIOMEDICAL SCIENCES. OUR...

Read more

EDUCATION: EDUCATION IS A VITAL PART OF MEMORIAL SLOAN-KETTERING CANCER CENTER'S MISSION. OUR TRAINING PROGRAMS PREPARE PHYSICIANS AND SCIENTISTS FOR CAREERS IN THE BIOMEDICAL SCIENCES. OUR COLLABORATIONS WITH THE ROCKEFELLER UNIVERSITY, CORNELL UNIVERSITY, AND WEILL MEDICAL COLLEGE OF CORNELL UNIVERSITY OFFER PHD PROGRAMS IN CHEMICAL BIOLOGY, COMPUTATIONAL BIOLOGY AND MEDICINE, AND THE MEDICAL SCIENCES. THE CENTER ALSO PARTNERS WITH WEILL MEDICAL COLLEGE AND THE ROCKEFELLER UNIVERSITY TO OFFER A MD/PHD DEGREE FOR ASPIRING PHYSICIAN-SCIENTISTS. THE CENTER HAS A PHD PROGRAM IN CANCER BIOLOGY THROUGH ITS LOUIS V. GERSTNER, JR. GRADUATE SCHOOL OF BIOMEDICAL SCIENCES. THIS NOVEL PROGRAM HAS BEEN ENROLLING STUDENTS SINCE 2006 AND TRAINS BASIC LABORATORY SCIENTISTS TO WORK IN RESEARCH AREAS DIRECTLY RELEVANT TO CANCER AND OTHER HUMAN DISEASES. WE ALSO OFFER POSTGRADUATE CLINICAL FELLOWSHIPS TO TRAIN PHYSICIANS WHO SEEK SPECIAL EXPERTISE IN A PARTICULAR TYPE OF CANCER AND POSTGRADUATE RESEARCH FELLOWSHIPS THAT PROVIDE PHYSICIANS AND SCIENTISTS WITH ADVANCED LABORATORY RESEARCH TRAINING. WITH FACULTY APPOINTMENTS AT THE WEILL MEDICAL COLLEGE OF CORNELL UNIVERSITY, OUR CLINICAL STAFF ALSO TRAIN RESIDENTS AND MEDICAL STUDENTS.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Sign In — Free (10 views/day)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $730,582,000
Program Service Revenue $6,306,939,000
Investment Income $306,904,066
Other Revenue $118,198,934
TOTAL REVENUE $7,462,624,000

Expense Breakdown

Grants Paid $27,561,322
Salaries & Benefits $3,711,817,811
Fundraising Expenses $79,820,612
Program Expenses $7,079,800,094
Other Expenses $3,449,330,265
TOTAL EXPENSES $7,188,709,398

Year-over-Year Comparison

2023 2022 Change
Revenue $7,462,624,000 $7,251,947,000 +0.0%
Expenses $7,188,709,398 $6,852,007,000 +0.0%
Net Income $273,914,602 $399,940,000 -0.3%
Key Indicators
✓ Grants to Organizations ✓ Grants to Individuals ✓ Lobbying ✗ Political Activity ✓ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required
🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Sign In

Governance

Voting Members
111
Independent Members
102
Employees
25365
Volunteers
370

Governance Policies

✗ Conflict of Interest Policy
✗ Whistleblower Policy
✗ Document Retention Policy

Special Practices & Reported Activities

✓ Operated a School
✗ Operated a Hospital
✗ Provided First Class Travel
⚠ Reported Conflict of Interest
✗ Reported Asset Diversion
✗ Excess Benefit Transaction
✗ Made Political Expenditures
✓ Engaged in Lobbying
✗ Operated Donor Advised Fund
✗ Maintained Art Collections
✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers
27
$38,727,956
Total Directors
39
$18,732,541
Key Employees
0
$0
Highest Compensated
5
reported
Name Title Hours/Week Role Reportable Comp Other Comp Total
N/A SVP & CHIEF RISK OFFICER 50.0
Officer Director
$1,136,118 $46,654 $1,182,772
N/A SEE SCHEDULE O 11.0
Officer Director
$0 $0 $0
N/A SEE SCHEDULE O 12.0
Officer Director
$0 $0 $0
N/A SEE SCHEDULE O 6.0
Officer Director
$0 $0 $0
N/A CHIEF OPERATING OFFICER (UNTIL 3/23) 50.0
Officer Director
$4,698,854 $63,637 $4,762,491
N/A SEE SCHEDULE O 16.0
Officer Director
$0 $0 $0
N/A SEE SCHEDULE O 14.0
Officer Director
$0 $0 $0
N/A VP, FINANCE (UNTIL 2/23) 50.0
Officer Director
$1,766,755 $15,004 $1,781,759
N/A EVP & CHIEF FINANCIAL OFFICER 50.0
Officer Director
$2,334,269 $64,501 $2,398,770
N/A SEE SCHEDULE O 16.0
Officer Director
$0 $0 $0
N/A BOARD MEMBER, PRESIDENT AND CHIEF EXECUTIVE 50.0
Officer Director
$5,489,537 $297,622 $5,787,159
N/A SEE SCHEDULE O 11.0
Director
$0 $0 $0
N/A SEE SCHEDULE O 6.0
Director
$0 $0 $0
N/A SEE SCHEDULE O 6.0
Director
$0 $0 $0
N/A SEE SCHEDULE O 6.0
Director
$0 $0 $0
N/A SEE SCHEDULE O 6.0
Director
$0 $0 $0
N/A SEE SCHEDULE O 8.0
Director
$0 $0 $0
N/A SEE SCHEDULE O 8.0
Director
$0 $0 $0
N/A SEE SCHEDULE O 2.0
Director
$0 $0 $0
N/A SEE SCHEDULE O 6.0
Director
$0 $0 $0
N/A SEE SCHEDULE O 6.0
Director
$0 $0 $0
N/A SEE SCHEDULE O 11.0
Director
$0 $0 $0
N/A SEE SCHEDULE O 6.0
Director
$0 $0 $0
N/A SEE SCHEDULE O 2.0
Director
$0 $0 $0
N/A SEE SCHEDULE O 6.0
Director
$0 $0 $0
N/A SVP, PARTNERSHIP OPERATIONS (UNTIL 10/23) 50.0
Director
$804,288 $77,441 $881,729
N/A SEE SCHEDULE O 6.0
Director
$0 $0 $0
N/A SEE SCHEDULE O 6.0
Director
$0 $0 $0
N/A SEE SCHEDULE O 6.0
Director
$0 $0 $0
N/A SEE SCHEDULE O 13.0
Director
$0 $0 $0
N/A SEE SCHEDULE O 6.0
Director
$0 $0 $0
N/A SEE SCHEDULE O 6.0
Director
$0 $0 $0
N/A CHAIRMAN ATTENDING 50.0
Director
$1,872,269 $65,592 $1,937,861
N/A SEE SCHEDULE O 6.0
Director
$0 $0 $0
N/A SEE SCHEDULE O 8.0
Director
$0 $0 $0
N/A SEE SCHEDULE O 6.0
Director
$0 $0 $0
N/A SEE SCHEDULE O 6.0
Director
$0 $0 $0
N/A SEE SCHEDULE O 6.0
Director
$0 $0 $0
N/A SEE SCHEDULE O 6.0
Director
$0 $0 $0
N/A SVP OF FACILITIES MANAGEMENT & REAL ESTATE DEVELOPMENT (UNTIL 10/23) 50.0
Officer
$1,063,117 $30,628 $1,093,745
N/A EVP, CHIEF STRATEGY OFFICER (EFF 5/23) 50.0
Officer
$544,669 $35,845 $580,514
N/A VP, DEPUTY GENERAL COUNSEL & CORPORATE SECRETARY 50.0
Officer
$565,599 $65,538 $631,137
N/A EVP, CHIEF MARKETING & COMMUNICATION OFFICER 50.0
Officer
$985,689 $45,086 $1,030,775
N/A EVP HOSPITAL ADMINISTRATION (UNTIL 2/23) 50.0
Officer
$1,112,947 $65,249 $1,178,196
N/A SVP & CHIEF INVESTMENT OFFICER 50.0
Officer
$3,498,969 $82,476 $3,581,445
N/A CHIEF SCIENTIFIC OFFICER 50.0
Officer
$1,890,877 $75,780 $1,966,657
N/A EVP & GENERAL COUNSEL 50.0
Officer
$1,508,282 $82,296 $1,590,578
N/A SVP, CHIEF DEVELOPMENT OFFICER 50.0
Officer
$1,921,418 $70,484 $1,991,902
N/A SR VP/CHIEF HUMAN RESOURCES OFCR (UNTIL 3/23) 50.0
Officer
$1,702,273 $79,897 $1,782,170
N/A EVP, CHIEF ADMINISTRATIVE OFFICER (EFF 3/23) 50.0
Officer
$616,975 $57,205 $674,180
N/A CHIEF PHYSICIAN EXECUTIVE 50.0
Officer
$2,134,180 $76,428 $2,210,608
N/A EVP, CHIEF DIGITAL OFFICER 50.0
Officer
$1,589,476 $71,898 $1,661,374
N/A HOSPITAL PRESIDENT (EFF 9/23) 50.0
Officer
$853,032 $26,400 $879,432
N/A EVP, INTERIM CHIEF HUMAN RESOURCES OFFICER (EFF 3/23) 50.0
Officer
$898,519 $71,031 $969,550
N/A Senior Vice President & Chief Nursing Executive 50.0
Officer
$952,138 $40,604 $992,742
N/A CHIEF ATTENDING 50.0
Highest
$2,574,038 $81,968 $2,656,006
N/A CHAIRMAN ATTENDING 50.0
Highest
$2,932,925 $77,726 $3,010,651
N/A ASSISTANT ATTENDING 50.0
Highest
$2,101,218 $65,486 $2,166,704
N/A ASSISTANT ATTENDING 50.0
Highest
$2,260,541 $59,601 $2,320,142
N/A ASSOCIATE ATTENDING 50.0
Highest
$2,082,394 $76,026 $2,158,420
N/A FORMER PRESIDENT & CEO 50.0
$2,021,713 $70,070 $2,091,783
N/A Former Officer 0.0
$1,077,404 $0 $1,077,404
Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year Revenue Expenses Assets Net Income
2024 No data No data No data No data
2023 $7,462,624,000 $7,188,709,398 $14,659,485,000 $273,914,602
2022 $7,251,947,000 $6,852,007,000 $13,998,385,000 $399,940,000
2021 $6,930,810,000 $6,144,357,000 $14,941,252,000 $786,453,000
2020 $5,383,849,774 $5,799,378,774 $13,315,250,000 $-415,529,000
2019 $5,561,914,000 $5,259,261,000 $11,621,453,000 $302,653,000
2018 $5,118,490,000 $4,659,570,111 $10,620,542,000 $458,919,889
Explore More Nonprofits
→Top 100 Nonprofits in New York →Largest U.S. Nonprofits →Best Rated Nonprofits →Most Efficient Nonprofits

Compare MEMORIAL SLOAN-KETTERING CANCER CENTER with other nonprofits in New York and across the country.

We Value Your Privacy
We use cookies and similar technologies to analyze site traffic and improve your experience. By clicking "Accept All", you consent to our use of cookies for analytics and measurement.